Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

IBRX US Equity

ImmunityBio, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1326110 · FY ends Dec 31
$8.13
+0.41 (+5.31%)
USD · as of 2026-08-19 · marketstack

Documents

6 of 6 10-Ks readable here
Period endFiledFormRead hereEDGAR
2025-12-312026-02-2310-Kread · risk factors · MD&Aindex · original · 0001326110-26-000030
2024-12-312025-03-0310-Kread · risk factors · MD&Aindex · original · 0001326110-25-000033
2023-12-312024-03-1910-Kread · risk factors · MD&Aindex · original · 0001326110-24-000037
2022-12-312023-03-0110-Kread · risk factors · MD&Aindex · original · 0001326110-23-000018
2021-12-312022-03-0110-Kread · risk factors · MD&Aindex · original · 0001326110-22-000011
2020-12-312021-03-0410-Kread · risk factors · MD&Aindex · original · 0001564590-21-010945

Risk registerwhich risk-factor headings appeared in which year

121 captions · 6 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

121 captions across 6 filings45 added62 dropped14 in every year6 of 6 10-Ks on file are cached here
Risk-factor caption202020212022202320242025Years
·····1
····2
····2 rw
····2
····2
····2
···3
···3 rw
···3
···3 rw
···3 rw
··4
··4 rw
··4 rw
··4 rw
··4 rw
·5 rw
·5
·5
·5
·5
·5 rw
·5
·5 rw
·5
·5 rw
·5 rw
·5
·5
·5 rw
·5 rw
·5 rw
·5 rw
·5 rw
·5
·5 rw
·5
·5
·5 rw
·5
·5 rw
·5
·5
·5
·5
·····1
····2 rw
·····1
·····1
·····1
···3 rw
···3
·····1
···3
···3
···3
···3
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·5
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
·····1
6 rw
6 rw
6
6
6 rw
6 rw
6 rw
6 rw
6
6 rw
6 rw
6
6 rw
6 rw
The filer's own 10-K text · 6 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

Filing languagedocument length, negation and hedging — chart it against price on GRAPH

6 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

FiledPeriod endDocument wordsItem 1A wordsNegation / 10kHedging / 10kFiling
2021-03-042020-12-3192,41933,00772.6173.12read · EDGAR ↗
2022-03-012021-12-31113,64741,89666.26183.2read · EDGAR ↗
2023-03-012022-12-31123,72447,67865.55186.63read · EDGAR ↗
2024-03-192023-12-31134,32052,38064.03186.94read · EDGAR ↗
2025-03-032024-12-31148,16656,74061.08179.06read · EDGAR ↗
2026-02-232025-12-31143,11859,57360.23180.41read · EDGAR ↗

plot against the price on GRAPH: Document length · Item 1A length · Negation per 10k words · Hedging per 10k words

The filer's own 10-K text · 6 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.